Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Front Endocrinol (Lausanne) ; 15: 1306091, 2024.
Article in English | MEDLINE | ID: mdl-38686208

ABSTRACT

Purpose: Whether the diagnosis of non-alcoholic fatty liver disease or metabolic dysfunction-associated fatty disease has a different impact on liver transplant recipients with hepatocellular carcinoma is not yet clear. Methods: Data from a two-center retrospective cohort study were collected to compare and investigate the differences between non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in clinicopathologic parameters and prognosis among liver transplant recipients with hepatocellular carcinoma. Results: A total of 268 liver transplant recipients with hepatocellular carcinoma were included. The prevalence among pre- and post-transplant metabolic dysfunction-associated fatty liver disease was 10.82% and 30.22%, while for non-alcoholic fatty liver disease, it was 7.09% and 26.87%, respectively. The clinicopathological parameters were similar between the two pre-transplant groups. In contrast, the post-transplant group with metabolic dysfunction-associated fatty liver disease exhibited a higher prevalence of diabetes mellitus and a greater body mass index. However, the other parameters were similar between the two post-transplant groups (p > 0.05). Factors such as the largest tumor size > 4 cm, microvascular invasion, lack of tumor capsule, post-transplant metabolic dysfunction-associated fatty liver disease, and decreased post-transplant lymphocyte percentage were related to an increased risk of recurrence. Conclusion: In patients undergone liver transplantation for hepatocellular carcinoma, the diagnosis of metabolic dysfunction-associated fatty disease is more strongly associated with metabolic abnormalities than the diagnosis of non-alcoholic fatty liver disease and is an independent predictor of hepatocellular carcinoma recurrence.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Liver Transplantation , Non-alcoholic Fatty Liver Disease , Humans , Carcinoma, Hepatocellular/surgery , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/pathology , Liver Transplantation/adverse effects , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/surgery , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/pathology , Non-alcoholic Fatty Liver Disease/diagnosis , Male , Female , Liver Neoplasms/surgery , Liver Neoplasms/metabolism , Liver Neoplasms/diagnosis , Middle Aged , Retrospective Studies , Prognosis , Adult , Aged
2.
J Org Chem ; 89(5): 3644-3651, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38377490

ABSTRACT

A highly adaptable asymmetric synthetic route toward dihydronaphthalene lignans was developed, with its application to the syntheses of negundin B and vitexin 1/6 described herein. This developed pathway proceeded through an enantioselective aldol reaction to establish the contiguous stereocenters present in the final structures with subsequent functional group transformations yielding (-)-negundin B and (-)-vitexin 1/6. The enantioselective synthesis of vitexin 1/6 allowed the correction of absolute configuration, which has been widely incorrectly reported.

3.
Eur J Clin Nutr ; 78(2): 107-113, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37935889

ABSTRACT

BACKGROUND: Metabolic dysfunction-associated fatty liver disease was proposed by international consensus to redefine the metabolic abnormal condition. However, its impact on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma has not been explored. METHODS: A two-center retrospective cohort study on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma was performed to analyze the impact of metabolic dysfunction-associated fatty liver disease on the clinicopathologic parameters and prognosis. RESULTS: There were 201 liver transplant recipients enrolled from two hospitals in our study. The pre- and post-transplant prevalences of metabolic dysfunction-associated fatty liver disease were 9.95% and 28.86%, respectively. The clinicopathological parameters revealed a similarity between patients with and without pre-transplant metabolic dysfunction-associated fatty liver disease. In contrast, the group with post-transplant metabolic dysfunction-associated fatty liver disease was linked with older age, a higher hepatitis recurrence rate and incidence of cardiovascular disease, usage of calcineurin inhibitors, a greater body mass index and waist circumference, lower albumin and high-density lipoprotein cholesterol levels, and poorer tumor-free survival and overall survival. The multivariate analysis showed the largest tumor size >4 cm (95% confidence intervals: 0.06~0.63, p = 0.006), microvascular invasion (95% confidence intervals: 1.61~14.92, p = 0.005), post-transplant metabolic dysfunction-associated fatty liver disease (95% confidence intervals: 1.40~10.60, p = 0.009), and calcineurin inhibitors-based regimen (95% confidence intervals: 0.33~0.96, p = 0.036) were the independent risk factors for recurrent hepatocellular carcinoma. CONCLUSIONS: Our study suggests that post-transplant metabolic dysfunction-associated fatty liver disease is more closely to metabolic abnormalities and that it can help identify liver transplant recipients at high risk of recurrent hepatocellular carcinoma.


Subject(s)
Carcinoma, Hepatocellular , Hepatitis B , Liver Neoplasms , Liver Transplantation , Non-alcoholic Fatty Liver Disease , Humans , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/surgery , Hepatitis B virus , Liver Neoplasms/etiology , Liver Transplantation/adverse effects , Retrospective Studies , Calcineurin Inhibitors , Non-alcoholic Fatty Liver Disease/complications , Hepatitis B/complications
4.
J Cell Mol Med ; 27(16): 2362-2371, 2023 08.
Article in English | MEDLINE | ID: mdl-37357501

ABSTRACT

Allogeneic blood vessels are regarded as one of the best natural substitutes for diseased blood vessels due to their good vascular compliance and histocompatibility. Since the supply and demand of allograft blood vessels do not always match in time and space, a good preservation scheme for isolated blood vessels is essential. The abdominal aortas of 110 male Sprague-Dawley (SD) rats were randomly divided into three groups, including cold storage group (4°C) (CSG), frozen storage group (FSG) and ambient storage group (25 ± 2°C) (ASG). Seven time points of preservation for 1, 3, 5, 7, 14, 30 and 90 days were set for detection. The changes in vascular physiological function were evaluated by MTT test and vasoconstriction ability detection, and the changes in vascular wall structure were evaluated by the tension tolerance test and pathological staining. The vascular function of CSG was better than FSG within first the 7 days, but the result was opposite since the 14th day. The vascular wall structure, collagen and elastic fibres of vessels, in CSG, showed oedema within 30 days, and continuous disintegration and rupture at 90 days. The vessel wall structure of FSG remained intact within 90 days. The tensile strength of the vessels in CSG was better than that in FSG within 5 days, and there was no statistical difference between the two groups between the 7th and 30th day, and then, the FSG was higher than CSG on the 90th day. Both cold storage and frozen storage could be applied as safe and effective preservation schemes for isolated rat artery within first 30 days. Cold storage is recommended when the storage time is <14 days, and then, frozen storage is better.


Subject(s)
Endothelium, Vascular , Vasoconstriction , Rats , Male , Animals , Rats, Sprague-Dawley , Cryopreservation , Aorta, Abdominal
5.
World J Clin Cases ; 10(27): 9703-9713, 2022 Sep 26.
Article in English | MEDLINE | ID: mdl-36186177

ABSTRACT

BACKGROUND: Gemcitabine plus nab-paclitaxel (GA) is a commonly used first-line treatment regimen for metastatic pancreatic cancer, and many studies will add a novel targeted agent to this regimen for improving patient survival rate. However, the clinical effectiveness of GA is the most controversial issue. AIM: To compare the efficacy and safety of GA regimen with a targeted agent and GA regimen. METHODS: Up to 1 December 2021, the eligible randomized controlled trials (RCTs) relating to GA and GA with a targeted agent were searched on PubMed, EMBASE and Cochrane Library for eligible data. We screened out appropriate studies for overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and toxicity, which had been pooled and finally analyzed by using Stata version 15.1. In addition, we use Reference Citation Analysis (https://www.referencecitationanalysis.com/) to collect the latest related literature to improve the latest cutting-edge research results. RESULTS: Seven RCTs involving 1544 patients (848 men and 696 women) were included. There were no significant differences between GA with a targeted agent and GA in PFS [hazard ratio (HR): 1.18 95% confidence interval (CI): 0.91-1.53], OS (HR: 1.12 95%CI: 0.99-1.27), and ORR (HR: 0.96 95%CI: 0.71-1.29). There was no notable difference in the two groups in grade 3/4 toxicity (fatigue, anemia, vomiting and neutropenia), whereas the incidence of grade 3/4 diarrhea considerably increased in GA with a targeted drug. CONCLUSION: Adding a novel targeted agent to the GA regimen did not improve survival rate of patients with metastatic pancreatic cancer.

6.
Environ Sci Pollut Res Int ; 29(7): 9766-9779, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34508309

ABSTRACT

Elevated vanadium in the environment adversely affects organisms, including plants, animals, and humans. Plants act as the main conduit for environmental vanadium to enter the food chain, and simultaneously their growth response characteristics reflect vanadium toxicity efficacy for plants. The aim of the present study is to investigate lettuce (Lactuca sativa L.) growth involving morphological change, physiological adjustment, vanadium accumulation under vanadium stress, and the potential health risk (expressed as health risk index (HRI)) of adults and children who consume it. Lettuce was grown in nutrient solution with 0, 0.1, 0.5, 2.0, and 4.0 mg L-1 of pentavalent vanadium [V(V)]. Results showed that 0.1 mg L-1 V did not significantly affect lettuce growth versus control, and marked depression arose at ≥ 0.5 mg L-1 V. Foliar proline increased rapidly at ≥ 0.5 mg L-1 V. No striking change emerged in leaf cell membrane permeability at all treatments. V(V) and total vanadium concentration in plant tissues were ordered as root > stem > leaf, while tetravalent vanadium [V(IV)] was leaf > root > stem. No health risk (HRI < 1) exists for adults and children who consume lettuce at control treatment. However, the health risk occurs (HRI ˃ 1) when they both ingest the seedlings exposed to ≥ 0.1 mg L-1 V, and the risk overall markedly increases with increasing vanadium. Therefore, enough attention needs to be paid to the human health associated with the ingestion of vegetables like lettuce grown in substrata contaminated by vanadium.


Subject(s)
Lactuca , Vegetables , Humans , Plant Leaves , Seedlings , Vanadium
7.
RSC Adv ; 8(22): 12138-12145, 2018 Mar 26.
Article in English | MEDLINE | ID: mdl-35539400

ABSTRACT

Ni-Co-Al2O3 composite coatings were prepared by pulsed electrodeposition and electrophoresis-electrodeposition on aluminum alloy. The content of Al2O3 particles of the Ni-Co-Al2O3 composite coating prepared by electrophoresis-electrodeposition was significantly higher than the composite coating prepared by pulsed electrodeposition. The composite coating prepared by electrophoresis-electrodeposition exhibited a better anti-wear performance than that prepared by pulsed electrodeposition. The morphology, composition and microstructure of the composite coatings were determined by means of X-ray diffractometer (XRD) and scanning electron microscopy (SEM). The hardness and friction properties of the samples were tested on the microhardness tester and the friction and wear loss tester respectively.

8.
Oncol Rep ; 30(5): 2153-60, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23970286

ABSTRACT

Obesity increases the risk of gastric cancer and may promote its growth, as was recently demonstrated by our novel in vivo mouse model. However, the underlying mechanisms of this correlation remain unclear. The purpose of this study was to investigate the precise effects of obesity on gastric cancer growth and to elucidate the potential molecular mechanisms. Diet-induced obese mice were insulin-resistant, glucose-intolerant and had high serum visfatin concentration. In the subcutaneous mouse model, tumors were more aggressive in diet-induced obese mice compared with lean mice. Tumor weights showed a significant positive correlation with mouse body weights, as well as serum insulin and visfatin concentrations. Immunohistochemical staining showed that the expression levels of iNampt, Sirt1 and c-MYC proteins were upregulated in the subcutaneous tumors from obese mice compared to those from lean animals. Furthermore, obesity not only prompted significantly murine forestomach carcinoma cell migration, proliferation, but also affected cellular apoptosis and cell cycle by endocrine mechanisms. These were associated with increased expression of the pro-survival nampt/sirt1/c-myc positive feedback loop confirmed by RT-PCR and western blotting. These results suggested that diet-induced obesity could promote murine gastric cancer growth by upregulating the expression of the nampt, sirt1 and c-myc genes.


Subject(s)
Cytokines/metabolism , Nicotinamide Phosphoribosyltransferase/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Sirtuin 1/metabolism , Stomach Neoplasms/pathology , Animals , Apoptosis/genetics , Cell Line, Tumor , Cytokines/genetics , Feedback, Physiological , Gene Expression Regulation, Neoplastic , Humans , Mice , Nicotinamide Phosphoribosyltransferase/genetics , Obesity/complications , Obesity/diet therapy , Obesity/pathology , Proto-Oncogene Proteins c-myc/genetics , Sirtuin 1/genetics , Stomach Neoplasms/etiology , Stomach Neoplasms/genetics
9.
J Biomater Sci Polym Ed ; 24(12): 1472-83, 2013.
Article in English | MEDLINE | ID: mdl-23829459

ABSTRACT

Human hepatocellular carcinoma (HCC) is one of the major causes of death worldwide. To investigate the relative importance of active and passive targeting strategies, the synthesis, characterization, in vitro uptake, and in vivo biodistribution of specific sulfapyridine HPMA (HPMA: N-(2-hydroxypropyl methacrylamide)) copolymer (sulfapyridine: SPD) conjugates, nonspecific HPMA copolymer conjugates, and DTPA are described in this study. The poly(HPMA)-SPD-DTPA (DTPA: diethylenetriaminepentaacetic acid), poly(HPMA)-DTPA, and DTPA conjugates were radiolabeled with the radionuclide (99m)Tc and tested for uptake by cultured H22 cells. The cellular accumulation of poly(HPMA)-SPD-DTPA-(99m)Tc complex was found to be time-dependent. The poly(HPMA)-SPD-DTPA-(99m)Tc tracer exhibited rapid uptake kinetics in cell culture with a t(1/2) of ~5 min. The uptake of poly(HPMA)-SPD-DTPA-(99m)Tc was significantly higher than that of poly(HPMA)-DTPA-(99m)Tc, indicating that the uptake of the poly(HPMA)-SPD-DTPA-(99m)T was active binding. The uptake of poly(HPMA)-DTPA-(99m)Tc was significantly higher than that of DTPA-(99m)Tc, suggesting that the uptake of the poly(HPMA)-DTPA-(99m)T was passive binding. Twenty-four hour necropsy data in the hepatocellular carcinoma tumor model showed significantly higher (p < 0.001) tumor localization for poly(HPMA)-SPD-DTPA-(99m)Tc (4.98 ± 0.48%ID/g [percentage injected dose per gram tissue]) compared with poly(HPMA)-DTPA-(99m)Tc (2.69 ± 0.15% ID/g) and DTPA-(99m)Tc (0.83 ± 0.03%ID/g). Moreover, higher T/B for poly(HPMA)-SPD-DTPA-(99m)Tc indicated reduced extravazation of the targeted polymeric conjugates in normal tissues. Specific molecular targeting and nonspecific vascular permeability are both significant in the relative tumor localization of poly(HPMA)-SPD-DTPA-(99m)Tc. Extravascular leak in nonspecific organs appears to be a major factor in reducing the T/B for the sulfapyridine molecules. Thus, the poly(HPMA)-SPD-DTPA is expected to be used as the potential macromolecular targeting carrier for hepatoma carcinoma in mice.


Subject(s)
Acrylamides/chemical synthesis , Pentetic Acid/analogs & derivatives , Polymethacrylic Acids/chemical synthesis , Polymethacrylic Acids/pharmacokinetics , Radiopharmaceuticals/chemical synthesis , Acrylamides/chemistry , Acrylamides/pharmacokinetics , Animals , Carcinoma, Hepatocellular/diagnostic imaging , Carcinoma, Hepatocellular/metabolism , Cell Line, Tumor , Drug Delivery Systems , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/metabolism , Male , Mice , Neoplasm Transplantation , Pentetic Acid/chemical synthesis , Pentetic Acid/chemistry , Pentetic Acid/pharmacokinetics , Polymethacrylic Acids/chemistry , Radionuclide Imaging , Radiopharmaceuticals/chemistry , Radiopharmaceuticals/pharmacokinetics , Technetium , Tissue Distribution
10.
Yi Chuan ; 24(2): 131-6, 2002 Mar.
Article in Chinese | MEDLINE | ID: mdl-16118124

ABSTRACT

The HLA-DRB1 gene polymorphism in Lahu ethnic of Yunnan, China was the first time investigated using high resolution PCR-SBT method, which is based on sequences of HLA-DRB1 Intron 1 and Intron 2 and with our improvement. From 55 individuals of Lahu ethnic 16 DRB1 alleles were detected. The three most common alleles were HLA-DRB1 * 12021(30.909%), 09012(15.455%), 15011(13.636%), and they covered 60% of the total alleles detected from Lahu ethnic.HLA-DRB1 * 1413, * 11081, * 1312, * 1418, * 1504 were the first time detected in the Chinese, and were very rare in worldwide ethnic groups. With comparison of HLA-DRB1 gene frequencies between various ethnic groups we analyzed the characteristics of HLA-DRB1 gene distribution in worldwide populations,and constructed the phylogenetic tree by Neighbor-joining method and Nei measure of genetic distance. The result showed Lahu ethnic obviously belong to the Chinese South ethnic groups and can't trace its origin from northern groups with the HLA-DRB1 genetic data. The preliminary explanations about the contradiction were given in this paper.

SELECTION OF CITATIONS
SEARCH DETAIL
...